Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
Abstract Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post-translational molecular features. To investigate the roles of protein glycosylation in the heterogeneity of high-grade serous ovarian carcinoma (HGSC), we perform mass spectrometry-based glycoproteomi...
Saved in:
| Main Authors: | Jianbo Pan, Yingwei Hu, Shisheng Sun, Lijun Chen, Michael Schnaubelt, David Clark, Minghui Ao, Zhen Zhang, Daniel Chan, Jiang Qian, Hui Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2020-12-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-020-19976-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mapping the O‐glycoproteome using site‐specific extraction of O‐linked glycopeptides (EXoO)
by: Weiming Yang, et al.
Published: (2018-11-01) -
A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers
by: Laurel K. Berry, et al.
Published: (2024-11-01) -
Risk Factors for Recurrence in Serous Borderline Ovarian Tumors and Early-Stage Low-Grade Serous Ovarian Carcinoma
by: Jingjing Zhang, et al.
Published: (2025-04-01) -
Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment
by: Kaylin M. Carey, et al.
Published: (2024-12-01) -
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
by: Stefan Bentink, et al.
Published: (2012-01-01)